Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

NCT03401060 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis
Systemic Mastocytosis

Interventions

DRUG: Denosumab
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]